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University, and Memorial Sloan-Kettering Cancer Center, New York, New YorkABSTRACT The aggregation of a-synuclein (a-Syn) is linked to Parkinson’s disease. The mechanism of early aggregation
steps and the effect of pathogenic single-point mutations remain elusive. We report here a single-molecule fluorescence study
of a-Syn dimerization and the effect of mutations. Specific interactions between tethered fluorophore-free a-Syn monomers on a
substrate and fluorophore-labeled monomers diffusing freely in solution were observed using total internal reflection fluores-
cence microscopy. The results showed that wild-type (WT) a-Syn dimers adopt two types of dimers. The lifetimes of type 1
and type 2 dimers were determined to be 197 5 3 ms and 3334 5 145 ms, respectively. All three of the mutations used,
A30P, E46K, and A53T, increased the lifetime of type 1 dimer and enhanced the relative population of type 2 dimer, with
type 1 dimer constituting the major fraction. The kinetic stability of type 1 dimers (expressed in terms of lifetime) followed the
order A30P (693 5 14 ms) > E46K (292 5 5 ms) > A53T (226 5 6 ms) > WT (197 5 3 ms). Type 2 dimers, which are
more stable, had lifetimes in the range of several seconds. The strongest effect, observed for the A30P mutant, resulted in a
lifetime 3.5 times higher than observed for the WT type 1 dimer. This mutation also doubled the relative fraction of type 2 dimer.
These data show that single-point mutations promote dimerization, and they suggest that the structural heterogeneity of a-Syn
dimers could lead to different aggregation pathways.INTRODUCTIONSelf-assembly of protein into amyloid-type aggregates is a
widespread phenomenon associated with the development
of many neurodegenerative diseases, including Parkinson’s
disease (PD), a hallmark of which is the aggregation of
a-synuclein (a-Syn) and the assembly of aggregates into
intracellular Lewy bodies (1,2). Amyloid self-assembly ki-
netics are described by a nucleation and growth mechanism
in which the first phase, nucleation, produces a critical
oligomer that gives rise to the second phase, a thermody-
namically favorable elongation process, resulting in the for-
mation of fibrillary aggregates (3). Biophysical techniques
have been applied in the structural characterization of amy-
loid or amyloid-like fibrils, revealing a number of general
features of aggregates formed by the assembly of amyloid
proteins, including a-Syn (4–7).
a-Syn is a relatively small protein comprised of 140 res-
idues that belongs to the family of intrinsically disordered
proteins (IDPs). In aqueous solution, the protein lacks clear
structural motifs and is characterized by a globular shape
slightly smaller than a random coil (6,7). In fibrils, however,
a-Syn undergoes a dramatic structural transition involving
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to as the nonamyloid component (NAC, amino acids 61–
95). Dramatic conformational transitions of this nature
typify fibrils formed by IDPs, whereas structurally orga-
nized amyloid proteins (e.g., Sup35 prion protein) can
form fibrils without undergoing such a dramatic structural
change (7). The key common feature of amyloid-like fibrils
is an extended b-sheet that stabilizes the fibrillar structure
(8,9). The conversion of amyloidogenic proteins to
b-sheet-rich assemblies involves a dramatic change in the
protein conformation that has been termed protein
misfolding.
Compared to our understanding of the elongation process,
knowledge of the first phase of a-Syn self-assembly, the for-
mation of oligomers, is limited due to the lack of appropriate
techniques to characterize temporal features of the assembly
process. Oligomeric states of the protein are transient, so
their characterization requires nontraditional approaches.
Single-molecule techniques are capable of characterizing
transient states of amyloid proteins (reviewed in (10,11)).
Sandal et al. applied atomic-force-microscopy (AFM)-
based single-molecule force spectroscopy (SMFS) to char-
acterize conformational equilibria of a-Syn monomers
(12). A number of environmental factors and pathogenic
mutations known to promote a-Syn aggregation were found
to shift the equilibria to structured conformers (13). Thehttp://dx.doi.org/10.1016/j.bpj.2015.03.010
Direct Detection of a-Syn Dimerization 2039same method was adopted by Herva´s et al. to reveal a
conformational polymorphism of monomeric forms of amy-
loidogenic proteins, including a-Syn (14). Optical tweezers
methods were applied to identify a range of metastable
structures for a-Syn monomers, dimers, and tetramers
(15). Trexler and Rhoades utilized single-pair Fo¨rster reso-
nance energy transfer to explore the aggregation-prone
states of a-Syn monomer (16), revealing an important role
of the C-terminus. Single-molecule Fo¨rster resonance
energy transfer was also used to demonstrate the structural
transition between the broken horseshoe and the extended
a-helix structures of a-Syn upon binding to lipids (17).
Based on our understanding of a-Syn fibrillar structure, dis-
cussed above, it is widely assumed that the aggregation of
a-Syn and other amyloid proteins is initiated by the forma-
tion of misfolded monomers and their assembly into dimers.
The monomer structure changes upon interaction with an
oligomer, and a detailed computational model of this pro-
cess, termed dock and lock, has recently been developed
(18). In that model, the unstructured monomer, after dock-
ing to the structured oligomer, adopts a conformation
required to lock the oligomer, adding one more unit to the
structured assembly.
Recently, our group developed an AFM-based SMFS
approach designed to monitor the interaction between
monomers tethered to the surface and the AFM tip
(11,19–28). Using this approach, misfolded states of
a-Syn and other proteins have been probed to reveal a num-
ber of common features. For example, we showed that di-
mers with different conformations form, and we identified
protein segments involved in the interprotein interaction.
In addition, the dimers were shown to be stable and charac-
terized by lifetimes in the range of 1 s.
The application of the SMFS approach to amyloid b (Ab)
proteins revealed dramatic differences in folding pattern be-
tween the Ab40 and Ab42 dimers, and the N-terminal
segment of the protein was found to play a critical role in
the protein folding (26). Probing of a-Syn interactions
enabled us to identify a-Syn segments involved in dimer
assembly and to characterize the impact of familial muta-
tions of a-Syn on the misfolded dimer conformations (24).
Evidence that misfolded dimers exhibit high stability led
to the hypothesis that the formation of such dimers is the
mechanism by which the misfolded state of amyloidogenic
proteins is stabilized, suggesting that dimerization triggers
the self-assembly process (11). Recent computational ana-
lyses confirmed this hypothesis (29). Molecular dynamics
(MD) simulations played an important role in demonstrating
that misfolded conformations did not occur in monomers
but did appear in dimers, which remained stable over time-
scales of several hundreds of nanoseconds, whereas mono-
mers changed their conformations in a few nanoseconds.
In addition, these studies revealed a set of misfolded dimeric
conformations, which led to our hypothesis that various
dimeric conformers are involved in the amyloid oligomeri-zation process. Although there is a nice qualitative correla-
tion between the high stability of dimers measured by SMFS
and that obtained in MD simulations, the dimers in the
experiment were probed along the applied force, so the
impact of dimer fluctuations in other directions on dimer
stability remains unclear. We address that issue in this study,
in which a single-molecule fluorescence approach was
developed to probe dimer stability.
Here, we applied single-molecule fluorescence imaging to
measure directly the lifetimes of a-Syn dimers. In this
approach, unlabeled a-Syn was tethered to the coverslips,
and fluorescently labeled a-Syn in the solution was capable
of interacting with the immobilized a-Syn to form dimers.
Dimer formation was detected by fluorescence bursts, and
dimer lifetimes were quantified. Statistical analysis revealed
long-lived dimers, with lifetimes exceeding hundreds of mil-
liseconds. In particular, we identified two major populations
of such dimers with lifetimes of several hundreds of millisec-
onds and several seconds, whose lifetimes and relative distri-
butions were altered by specific disease-related mutations.MATERIALS AND METHODS
Materials
Phosphate-buffered saline (PBS), pH 7.0, was prepared and filtered through
a disposable Millex-GP syringe filter unit (0.22 mm) before use. All re-
agents were purchased from Sigma Aldrich (St. Louis, MO). In all experi-
ments, we used square glass coverslips (20 mm  20 mm; Karl Hecht,
Sondheim, Germany), potassium dichromate (ICN Biomedicals, Aurora,
OH), and deionized (DI) water (18.2 MU resistivity, 0.22 mm filter pore
size; APS Water Services, Van Nuys, CA). A stock solution of 50 mM
1-(3-aminopropyl) silatrane (APS) was prepared by dissolving the APS
powder in DI water. The intramolecularly photostabilized Cy3 fluorophore
(GE Healthcare, Little Chalfont, United Kingdom) was chemically
synthesized (30). Maleimide-poly(ethylene glycol)-succinimidyl valerate
(Mal-PEG-SVA, 3.4 kDa), SVA-PEG-SVA, and methoxy-PEG-SVA
(mPEG-SVA, 2 KDa) were purchased from Laysan Bio (Arab, AL). In addi-
tion, we used sodium bicarbonate (Mallinckrodt Baker, Paris, KY), Amicon
10 kDa and 30 KDa centrifugal filter units (EMDMillipore. Billerica, MA),
mica sheets (Asheville-Schoonmaker Mica, Newport News, VA), carbon-
coated double-sided tape (Ted Pella, Redding, CA), and 0.1-mm-thick
teflon spacers (American Durafilm, Holliston, MA). All a-Syn proteins
were prepared as described in our previous publications (22,24), and details
are provided in the Supporting Material.Total internal reflection fluorescence microscopy
imaging
Glass coverslips were cleaned with potassium dichromate for 30 min and
immersed in DI water until use. Glass coverslips were assembled on the
original sample holder (PicoQuant, Berlin, Germany), then covered by a
0.1-mm-thick teflon spacer and a 25-mm-diameter quartz disk. The created
sample chamber was then filled with an aqueous solution of 167 mM APS
for 30 min and rinsed with DI water, resulting in a glass surface modified
with primary amine groups. The APS coverslips were functionalized with
a 1:100 Mal-PEG-SVA/mPEG-SVA molar mixture (31,32) by incubation
for 1 h in 0.1 M sodium bicarbonate buffer, pH 8.5 (33). Bubbles were
removed from the sodium bicarbonate buffer by vortexing and ultrasonica-
tion. The sample chamber was sequentially rinsed with sodium bicarbonateBiophysical Journal 108(8) 2038–2047
2040 Lv et al.buffer, pH 8.5, and 10 mM PBS buffer, pH 7.0, before immobilization of
a-Syn. The a-Syn solution was sonicated (Branson 1210, Branson Ultra-
sonics, Danbury, CT) and then filtered through an Amicon filter (molecular
weight cutoff, 30 kDa) at 14,000 rpm for 15 min to remove aggregates. For
surface immobilization, the a-Syn solution (25 pM fluorescently labeled or
unlabeled) was injected into the sample chamber to allow Cys moieties of
a-Syn to react with maleimide groups of immobilized Mal-PEG-SVA dur-
ing a 1 h incubation. The sample chamber was thoroughly rinsed with PBS
buffer solution and used immediately.
Single-molecule imaging was performed with an objective-type total in-
ternal reflection fluorescence (TIRF) microscope built around an Olympus
IX71 microscope (Hitschfel Instruments, St. Louis, MO). An oil-immer-
sion UPlanSApo 100 objective with 1.40 NA (Olympus, Tokyo, Japan)
was used for all measurements. A laser line at 532 nm (CrystaLaser,
Reno, NV) was used to excite the fluorophore of immobilized a-Syn in
the total internal reflection mode. Fluorescence emission was detected
with an electron-multiplying charge-coupled-device camera (ImagEM
Enhanced C9100-13, Hamamatsu, Bridgewater, NJ). TIRF videos of
45 s to 50 s duration were recorded at a temporal resolution of 30 ms.
The labeled 1 nM a-Syn solution (labeling procedures can be found in
the Supporting Material) was sonicated for 1 min to break aggregates
and filtered through an Amicon filter (molecular weight cutoff, 30 kDa)
at 14,000 rpm for 15 min. TIRF experiments were repeated three times
for each protein.
Double cysteinyl a-Syn enabling fluorescence labeling and covalent
immobilization was used in experiments in which the density of a-Syn sur-
face coverage was adjusted. Before the surface immobilization, a 100 pM
solution of Cy3 a-Syn was sonicated for 1 min to break aggregates and
filtered through an Amicon filter (molecular weight cutoff, 30 kDa) at
14,000 rpm for 15 min. The filtered a-Syn solution was immobilized on
the PEG-functionalized coverslips using the procedure described above.
The experiments were repeated three times.FIGURE 1 (A) Schematic of the structure of a-Syn. The amphipathic re-
gion (1–61), nonamyloid component region (NAC, 61–95), and acidic tail
(95–140) are colored dark gray, light blue, and light pink, respectively.
Arrows indicate the three single-point mutations, A30P, E46K, and A53T.
A cysteine is tagged at the C-terminus for single cysteinyl a-Syn. Two cys-
teines are placed at both ends for double cysteinyl a-Syn. (B) Schematic of
the TIRF setup. A glass coverslip is functionalized with APS, followed by
functionalization with two types of PEG and immobilization of the unla-
beled a-Syn. The solution of the labeled a-Syn (shown with red dots atTIRF data analysis
The videos recorded with TIRF were visually inspected frame by frame us-
ing Slidebook 5.0 software (Intelligent Imaging Innovations (3i), Denver,
CO). Whenever a candidate dimer was detected, a confined area was circled
out for further analysis. A typical dimerization event showed a sudden
increase of fluorescence intensity with an abrupt drop back to background
after a short time period. The increment threshold of fluorescence intensity
was set at three times higher than the standard deviation of background fluc-
tuation. Several hundreds of dimers were analyzed for each protein. The
data were assembled and shown as a distribution.
The normalized survival probability, Psurv, was used to measure the life-
time of a-Syn dimers. A prominent characteristic of the NSP approach is
that it does not require any assumptions about the type of data distribution
(34,35). Therefore, if the decay process is complicated (e.g., multiexponen-
tial), the NSP approach is capable of extracting features for all species. Psurv
was calculated by dividing the number of events that fall into each time-bin
interval by the total number of events. The original distribution of counts
versus lifetime was transformed into another display in which Psurv was
plotted versus lifetime according to the equation
Psurv ¼ nsurvðtÞ
N
; (1)
where nsurvðtÞ is the number of dimerization events that survive longer than
lifetime t, and N is the total number of dimerization events detected. one end) is injected into the sample chamber, allowing free a-Syn mole-
cules to interact with the tethered protein molecules. A laser is brought to
the sample in the total internal reflection mode, enabling the generation
of an evanescent field and excitation of molecules in the proximity of the
surface. The dimerization event is detected by the appearance of a fluores-
cence burst with duration t defining the dimer lifetime, as shown schemat-
ically (inset). To see this figure in color, go online.Compared with single- and triple- exponential decay (Table S1), the data
were best fitted with a double-exponential decay process, which we ascribe
to two types of dimers with distinct lifetimes, t1 and t2:
PsurvðtÞ ¼ A1  exp

t
t1

þ A2  exp

t
t2

(2)Biophysical Journal 108(8) 2038–2047where A1 and A2 are fractions of species with lifetimes t1 and t2,
respectively.
The Kolmogorov-Smirnov test (no assumption of data distribution
required) was used to test the difference between the two identified distri-
butions for each experiment.
The free energies were estimated according to methods in previous
studies, using the equation (36)
DG# ¼ ln

kBT
koff  h

kBT; (3)
whereDG# is the height of the energy barrier, kB is the Boltzmann constant,
T is temperature, h is the Planck constant, and koff (the reciprocal value of t1
and t2) is the dissociation rate without applied external force.
Single-molecule fluorescence traces of covalently immobilized a-Syn
were manually selected for analysis. The number of photobleaching steps
in each trace was determined according to published procedures (37). All
fluorescence traces contained only one or two bleaching steps. At least
100 molecules were analyzed for each sample.RESULTS
Tethered approach outline
We designed the approach for direct visualization of a-Syn
interactions at the single-molecule level using single-mole-
cule fluorescence in the TIRF mode. In this approach, sche-
matically shown in Fig. 1, a-Syn proteins (wild-type (WT)
and three mutants, A30P, E46K, and A53T (Fig. 1 A)) are
immobilized on a coverslip and allowed to interact with flu-
orescently labeled a-Syn in the solution to form a complex
Direct Detection of a-Syn Dimerization 2041(dimer). Dimer formation is detected by the appearance of a
fluorescence burst at the location of the transiently formed
dimer (Fig. 1 B). The duration of the burst is the measure
of the a-Syn dimer lifetime. To minimize the effect of
a-Syn immobilization on the interaction with free protein
molecules, a-Syn molecules were tethered to the surface
via flexible PEG linkers. We used bifunctional PEG tethers
that were covalently immobilized on the amino-modified
surface (i.e., the APS surface) (27) via the reaction of the
SVA terminal reactive group (the N-hydroxysuccinimide
group) making the maleimide terminus (Mal group) of im-
mobilized PEG available for reaction with the thiol group
of the a-Syn cysteine residue. a-Syn does not contain
cysteine residues, so we used an A140C derivative of
a-Syn in which the C-terminal alanine was replaced with
cysteine. The rationale for using the C-terminal domain
for a-Syn immobilization stems from the well-documented
fact that the C-terminal segment of a-Syn is not involved in
protein aggregation; therefore, C-terminal immobilization
via cysteine provides the fewest potential constraints for
the interaction of immobilized a-Syn with free protein.
Indeed, a similar immobilization of a-Syn was used in our
prior AFM force spectroscopy studies, in which the interac-
tions between two immobilized a-Syn proteins were probed
(11,19,22,24). The same terminal cysteine was used for fluo-
rescence labeling of a-Syn that was free in solution in the
experimental setup (Fig. 1 B). A number of critical issues
have to be addressed to accomplish the experiments as
described in the scheme (Fig. 1 B).
First, the duration of the dye fluorescence should be long
enough to enable us to measure the dimer lifetime before
fluorophore bleaching. To ensure slow photobleaching, we
used organic fluorophores that were photostabilized through
intramolecular triplet-state quenching (38). We tested the
stability of a given fluorophore conjugated to a-Syn in
experiments in which labeled a-Syn was covalently immo-
bilized on the PEG-ylated surface. In these experiments,
a-Syn containing two cysteines (one each at the N- and
C-termini) was used. One Cys residue enabled the conjuga-
tion of the dye, whereas the other provided immobilization
of Cy3-labeled molecules to the glass coverslips functional-
ized with PEG-maleimide. There was no blinking or bleach-
ing of the fluorescence spots during the observation time
(see Movie S1 and the time trajectory shown in Fig. S1).
Thus, these data directly confirmed the fluorescence stabil-
ity of the label within the protein and under the environ-
mental conditions used for these experiments. Second, the
surface coverage of a-Syn should be sparse, to avoid overlap
of fluorescence signals from labeled a-Syn bound to two
adjacent immobilized a-Syn molecules. This criterion was
met by adjusting the surface density of PEG-maleimide
and the a-Syn concentration. The surface density of PEG-
maleimide was controlled by the use of an excess of
mPEG-SVA along with the main tether, Mal-PEG-SVA,
both of which bind covalently to amines of the APS-glasssurface. Because mPEG-SVA does not have a reactive mal-
eimide group, the ratio between the two PEG tethers
allowed us to adjust the surface density of these groups as
needed for a-Syn immobilization. The conditions for the
surface preparation and a-Syn concentration were identified
by experiments with the use of Cy3-labeled a-Syn that con-
tained two cysteines at the N- and C-termini, as described
above. Fig. S2 A shows that individual bright spots were
well separated with the distance (approximately microns)
between the adjacent spots. Third, we tested the level of
nonspecific binding of a-Syn. The experiments using the
mPEG-SVA surface showed that the level of binding of
Cy3-labeled a-Syn is very low (cf. Fig. S2, A and B).
Nonspecific adsorption of dyes on other surfaces was also
tested (Fig. S3). Fourth, we ensured that immobilized
Cy3-labeled a-Syn was monomeric by performing photo-
bleaching experiments. The results shown in Movie S2
demonstrated that immobilized labeled a-Syn photo-
bleaches rapidly, as can be seen in the sample trajectory in
Fig. S2 C. Statistical analysis (Fig. S2 D) demonstrates
that 95% of cases were one-step bleaching events. Two-
step processes were observed in 5% of cases and were
assigned to dimer bleaching. Fifth, we need to take into
consideration the ability of a-Syn to self-assemble into
aggregates. The monomeric size of a-Syn was verified by
AFM imaging (Fig. S4; see also Shlyakhtenko et al. (39)).
This finding was in line with the low yield of two-step pho-
tobleaching experiments mentioned above (Fig. S2 D). A
potential contribution to the observed fluorescence bursts
from free-floating a-Syn is very small if any. Given the
diffusion coefficient of a-Syn of 2  106 cm2 s1 (40),
the characteristic time of translocation over the evanescent
area (~100 nm) is ~0.1 ms, which is beyond the temporal
resolution of the TIRF setup of the instrument (30 ms).
The five factors just described were critical in developing
the a-Syn immobilization procedure for reliable detection
of the a-Syn dimerization process. The concentration of
a-Syn for surface immobilization and the ratio between
PEGs were optimized to reach the required surface
coverage, as shown in Fig. S5.Visualization of a-Syn dimerization
Unlabeled WT a-Syn was tethered to the glass coverslip as
described above, and the solution of fluorescently labeled
WT a-Syn was placed on the top, so the binding process
of labeled molecules to immobilized unlabeled WT a-Syn
could be detected by continuous measuring of fluorescence
by the TIRF system. This dimerization process can be
seen in Movie S3 and Fig. S6, A–C (three frames from
Movie S3). Bright spots on the image frames correspond
to binding events, and the fluorescence duration defines
the protein-complex lifetime. For example, fluorescence
at spot 1 (Fig. S6, A–C, circle 1) is short, whereas spot 2
(circle 2) persists for a much longer time. These eventsBiophysical Journal 108(8) 2038–2047
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a selected set of such trajectories with different duration
times is shown in Fig. 2. The peak in Fig. 2 A represents a
complex formation event with a relatively short duration
time, t ¼ 0.21 s. Given the high stability of the fluorophore
conjugated with a-Syn, the abrupt drop in fluorescence in-
tensity after 0.21 s was assigned to the dissociation of the
complex rather than to photobleaching or photoblinking.
Fig. 2, B and C, corresponded to longer lived complexes
with lifetimes of 0.45 s and 1.29 s, respectively. Note
the very long-lived event, with a lifetime of 6.63 s, in
Fig. 2 D. It is important to note that all events had very
similar fluorescence intensity, suggesting that complexes
of the same stoichiometry are formed. The spots were pre-
dicted to be dimers formed by the immobilized a-Syn and
its fluorescent counterpart in solution. Trimerization would
lead to a two-step dissociation pattern that was rarely
observed in these experiments, since rather low concentra-
tions of labeled a-Syn were used. The process was revers-
ible, as suggested by the fact that multiple dissociationBiophysical Journal 108(8) 2038–2047and rebinding events were observed on the same trajectory
for a selected target (Fig. S7). Fig. S7 A illustrates two
consecutive binding-dissociation events at the same spot.
The lifetimes of the dimers indicated in the graph are quite
close. Fig. S7 B demonstrates three consecutive binding-
dissociation events involving the same target. The initial
event produces a dimer with a lifetime of 0.48 s, whereas
the next events lead to the formation of dimers with shorter
lifetimes.
Several hundreds of such events collected from different
experiments were analyzed, and the data, assembled as his-
tograms, are shown in Fig. 2 E. The majority of the events
were grouped at a lifetime of ~0.2 s, although events as
long as ~18 s could be found as well. The data were
analyzed using the NSP approach, which does not require
any assumptions about the type of data distribution
(34,35). Graphs are shown in Fig. 2 F, and the entire data
set is approximated by a double-exponential decay process,
with distinct decay times of 197 5 3 ms and 3334 5
145 ms assigned to type 1 and type 2 dimers, respectively.FIGURE 2 Typical fluorescence time traces of
WT a-Syn dimer with various lifetimes. Bursts
of fluorescence (arrows) represent the formation
of dimers by binding of a fluorophore-labeled
a-Syn to an immobilized a-Syn on the surface
with various lifetimes: 0.21 s (A), 0.45 s (B),
1.29 s (C), and 6.63 s (D). The concentrations of
labeled a-Syn in solution and unlabeled a-Syn
functionalized on the PEG-ylated surface are
1 nM and 25 pM, respectively. (E) Quantitative
analysis of the fluorescence data. Histogram of
lifetimes of WT a-Syn dimer (n ¼ 462). The
majority of fluorescence bursts are shown in the
inset of Fig. 2 E. (F) Normalized survival probabil-
ity graph in which the red circles are normalized
data points and the solid line is a fitting curve
approximated by a two-exponential decay equation
with lifetimes indicated in the graph. The errors are
fitting errors. The R-squared value indicates the
goodness of the fit. To see this figure in color,
go online.
Direct Detection of a-Syn Dimerization 2043The population of type 1 dimers was the most abundant
(90%), with only 10% of the detected dimers belonging to
long-lived type 2 assemblies. In each individual experiment,
two distinct lifetimes that differ by an order of magnitude
were consistently observed. To further validate the type 2
dimer, the Kolmogorov-Smirnov test was used to test the
difference between the two identified types of dimers. The
results showed that the two types of dimer differ substan-
tially from each other (p < 0.01) with respect to lifetime
(Table S2).Effects of mutations on dimer stability
Similar analysis was performed with three a-Syn mutants,
A30P, E46K, and A53T, corresponding to familial muta-
tions of Parkinson’s disease. The experimental setup was
similar to that for WT a-Syn, described above. Each
a-Syn mutant was tethered to the coverslips, and the solu-
tion of the same fluorescently labeled a-Syn mutant was
placed on top of the coverslip to allow free a-Syn moleculesto interact with the immobilized counterpart. Complex for-
mation was detected for these proteins as well (see Movies
S4, S5, and S6). Time traces of representative dimer forma-
tion and dissociation events for A30P, E46K, and A53T
a-Syn mutants are shown in Figs. S8, S9, and S10, respec-
tively. Similar to the results obtained with WT a-Syn
dimers, the lifetimes of mutant dimers varied in the range
between several hundreds of milliseconds and several sec-
onds. Histograms of dimer lifetimes for all mutants assem-
bled over several hundred events are shown in Fig. 3, A, C,
and E. The majority of lifetimes clustered at 0–0.5 s accom-
panied by spread-out events with lifetimes as long as several
dozens of seconds. Compared with the WT a-Syn data,
which showed the majority of lifetimes clustered around
100 and 200 ms (Fig. 2 E), the lifetimes of mutants were
shifted to larger values, indicating their higher dimer
stability relative to the WT. Note the strong maximum
of ~400 ms for the A30P mutant (Fig. 3 A). The NSP
approach was applied to these data sets, and the resulting
data for all mutants are shown in Fig. 3, B, D, and F. TheFIGURE 3 Quantitative analysis of the experi-
ments with a-Syn mutants A30P (A and B,
n ¼ 505), E46K (C and D, n ¼ 460), and A53T
(E and F, n ¼ 453). The concentrations of labeled
a-Syn in solution and unlabeled a-Syn functional-
ized on the PEG-ylated surface are 1 nM and
25 pM, respectively. (Insets in A, C, and E) Zooms
of the graphs, showing the majority of the fluores-
cence bursts spanning 0–3 s. For each mutant
dimer, the corresponding normalized survival prob-
ability is plotted against the lifetime and fitted with
a two-exponential decay equation (B, D, and F).
Red circles are normalized data points, solid lines
are fitting curves, and lifetimes are shown in the
graphs. The errors are fitting errors. R-squared
values indicate the goodness of the fit. To see this
figure in color, go online.
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data sets that led to lifetimes of type 1 dimers of A30P,
E46K, and A53T of 693 5 14 ms (Fig. 3 B), 292 5 5 ms
(Fig. 3 D), and 226 5 6 ms (Fig. 3 F), respectively,
averaged over three independent experiments. Altogether,
the stability of type 1 dimers is arranged in the order
A30P > E46K > A53T > WT. The lifetimes of type 2
dimers of A30P, E46K, and A53T were 4998 5 134 ms,
3593 5 140 ms, and 2931 5 104 ms, respectively, so the
stability of type 2 dimers (long-lived) decreases in the order
A30P > E46K z WT >A53T.
The distributions of type 1 and type 2 dimer populations
are summarized in Fig. 4. Compared to WT dimers, E46K
dimers had similar distribution (88% were type 1 dimer).
A30P dimers had the smallest portion of type 1 dimers
(78%) and possessed the longest lifetime of type 1 dimers
among all the variants. The fraction of type 1 dimer for
A53T (81%) was close to that of A30P but smaller than
that of WT.DISCUSSION
Conformational dynamics of a-Syn dimers
The proposed single-molecule fluorescence approach
enabled us to quantitatively characterize interactions be-
tween a-Syn molecules. Using this approach, we demon-
strated that the protein can form dimers with lifetimes
in the range of a second that correspond to a barrier
height as large as ~28 kBT (Table S3). Recently, the
AFM force spectroscopy approach was applied to charac-
terize a-Syn dimers (11,19,22), and the value of the
dimer lifetime was also on a timescale in the range of
seconds. However, AFM force spectroscopy probes dimer
stability along the direction of the applied force. The
correlation between the data obtained by two different
techniques suggests that the dimer dissociation along the
pulling direction has a similar barrier height. However,FIGURE 4 Relative populations of type 1 (short lifetime, gray column)
and type 2 (long lifetime, hatched column) dimers of WT, A30P, E46K,
and A53T dimers. The error bars are fitting errors.
Biophysical Journal 108(8) 2038–2047the fluorescence approach allowed us to identify dimers
with substantially longer lifetimes of several seconds,
termed type 2 dimers. Such stable a-Syn dimers were
also identified in the AFM force spectroscopy experiments,
but only at pH 2.7, whereas the fluorescence experiments
used here were performed at neutral pH. The yield of
rupture events of force measurements at neutral pH was
very low, but measurements at pH 5.1 provided only one
lifetime, t ¼ 0.23 s (19). The fluorescence data show
that the population of type 2 conformers of dimers is
~10%, so their detection with AFM force spectroscopy is
problematic. Therefore, we infer that primarily type 1 con-
formers are detected in the AFM force spectroscopy
experiments.
The experimental approach described here consisted of
an end-immobilization strategy involving the use of long
flexible PEG tethers containing ~77 units of ethylene gly-
col that allowed the entire a-Syn molecule to adopt almost
unrestricted conformations. In our force spectroscopy anal-
ysis of a-Syn (22,24), we showed that a C-terminal
segment as long as ~30 residues was not involved in the
interaction within the dimer, so tethering by the very end
of the molecule does not interfere with dimer folding.
Although the C-terminal domain of monomeric, unfolded
a-Syn has been shown to interact with the central
hydrophobic region via long-range interactions (41), the
authors model the dimer interactions that occur with
a-Syn molecules in solution under conditions where
long-range interactions are relieved. Evidence suggests
that the relief of these long-range interactions could pro-
mote dimerization and oligomerization (42). Moreover,
any surface properties that may have influenced a-Syn
dimerization in this study could be relevant to cellular olig-
omerization, based on evidence that membrane surfaces
promote the self-assembly of a-Syn and other amyloido-
genic proteins (43–45).
Although it has been widely assumed that the intracel-
lular state of a-Syn is monomeric, the very recent studies
of D. Selkoe et al. (46) suggest that a-Syn tetramers,
rather than monomers, are the primary endogenous state
of the protein, although others argue against this hy-
pothesis (47,48). The long-lived dimers may form either
potentially toxic oligomers (see below) or benign tetra-
mers, and the distribution of these two outcomes is likely
to vary among different a-Syn variants. We speculate that
the difference between the two types of dimers observed
here is in the stability of b-sheet structure, the major
contributor to a-Syn fibril formation. This interpretation
is supported by our recent computational analysis of
dimers formed by amyloid b (14–23) dimers, which
showed the formation of two stable amyloid b dimers
with different stabilities, as defined by b-sheet size (29).
We also speculate that long-lived dimer species may be
more neurotoxic compared to short-lived species. This
assumption is supported by a recent study (49) in which
Direct Detection of a-Syn Dimerization 2045the authors discovered two types of oligomer with distinct
neurotoxicity.Role of mutations in a-Syn dimerization and
aggregation
The comparative studies of WT a-Syn and all mutants
(Figs. 2 and 3) demonstrate that mutations enhance the life-
span of type 1 dimer and that the lifetime values decay in the
order A30P (6935 14 ms) > E46K (2925 5 ms) > A53T
(2265 6 ms) > WT (1975 3 ms). These lifetimes corre-
spond to energy barriers of 27.8 kBT, 29.1 kBT, 28.2 kBT, and
28.0 kBT for WT, A30P, E46K, and A53T, respectively
(Table S3). The longer lifetimes of type 1 dimers for the
mutants compared with WT suggested that the single-point
mutations promote dimerization along the type 1 pathway
and eventually the entire aggregation process of a-Syn.
The possibility that the dimeric species observed in this
study may be species on the a-Syn self-assembly pathway
leading to higher-order oligomers is suggested by the find-
ings that 1) dimerization is a key step in a-Syn self-assem-
bly (50–52); 2) familial a-Syn variants have been shown to
have a high propensity to form oligomers (7); and 3) the data
presented here suggest that familial mutations stabilize
dimeric forms of a-Syn. Of the three mutations, A30P exerts
the strongest effect on dimerization, causing a 3.5-fold in-
crease in the lifetime of type 1 dimer over the lifetime for
the WT. Only the A30P mutation increases the lifetime of
long-lived type 2 dimers. However, all three mutations
lead to an increase in the population of type 2 a-Syn dimer,
although the effect depends on the mutation type. All but
the A30P mutation accelerate a-Syn fibrillization kinetics
(53,54), whereas A30P induces an increase in the rate of
oligomerization (protofibril formation) (55,56). This partic-
ular mutant is different from the others, as well as from WT
a-Syn, based on its very long lifetimes for both types of
dimer and its relatively high population of type 2 dimers,
which was more than twofold higher than that of WT
a-Syn type 2 dimers. It has been shown recently that two
structurally different a-Syn oligomers coexist for all four
dimer species, A30P, E46K, A53T, and WT (57). One
type of oligomer was reported to result in fibrillization,
whereas the other was responsible for oligomerization.
The A30P mutation only promotes oligomerization and
retards fibrillization. Therefore, we speculate that oligomer-
ization propensity depends on the ability to form long-lived
dimers, and the high ratio between type 2 and type 1
A30P dimers promotes the oligomerization pathway. Addi-
tional dimer stabilization can be provided by oxidation
(58,59) and/or nitration (60) processes that could promote
protein aggregation in vivo.
Our finding that a-Syn forms dimers with different life-
times yields insights into the potential mechanisms of
a-Syn self-assembly. One possibility is that different types
of a-Syn dimers form different types of assemblies, consis-tent with structural heterogeneity of oligomeric and fibrillar
forms of a-Syn (8,15,49). Alternatively, some dimers could
be precursors of potentially toxic a-Syn oligomers, whereas
others are not (e.g., they could be precursors of benign tet-
ramers). Additional evidence from future studies will be
needed to determine which dimers lead to the formation
of potentially toxic a-Syn oligomers and thus should be
considered therapeutic targets. The data presented here
support the interpretation from our earlier studies (24) that
multiple contacts enhance the stability of dimeric, mutant
a-Syn. In turn, this enhanced dimer stability increases the
probability that dimeric a-Syn will proceed down the
a-Syn self-assembly pathway toward oligomers instead of
undergoing dissociation followed by rapid monomer remod-
eling (40,61).CONCLUSIONS
In summary, the single-molecule imaging approach devel-
oped here enabled us to measure the lifetimes of a-Syn
dimers that appeared to be on a timescale in the range of sec-
onds. Two classes of dimer with markedly different life-
times were discovered. a-Syn mutations involved in the
development of familial PD increase dimer stability, sug-
gesting that the disease onset is defined by dimer formation,
which is the very first aggregation event. Consistent with
these findings, a previous study revealed that dimer forma-
tion was accelerated for the pathogenic A30P and A53T
a-Syn mutants (50). The authors hypothesized that the
effect was due to the greater propensity of mutants to self-
interact, and our findings support this hypothesis. It is
important to note that dimer formation was detected in solu-
tions of nanomolar levels of a-Syn, suggesting that aggrega-
tion can occur at protein concentrations several orders of
magnitude lower than those typically used in amyloid aggre-
gation studies in solution in vitro. Although these low-con-
centration aggregation conditions were achieved in the
protein-tethered setup, in which a-Syn was immobilized
on the surface and dimers were formed by interaction of
the immobilized protein with a freely diffusing a-Syn, the
recent studies of Rabe et al. (62) showed that tethering of
the protein is not required and that aggregation of a-Syn
from a nanomolar-range solution can occur at the surface-
liquid interface. Moreover, aggregation on the surface
occurs more rapidly than in solution, regardless of the
very high protein concentration in solution, which is several
orders of magnitude higher than the concentrations used in
the on-surface aggregation studies. Surfaces of various types
are ubiquitous for intracellular and extracellular compart-
ments, so it is highly important to understand the accelera-
tion effect of surfaces in the protein self-assembly process.
The approach described in this article showed that the very
first self-assembly step, with the participation of the tethered
protein, occurs at a subnanomolar protein concentration
in solution and leads to the formation of stable dimersBiophysical Journal 108(8) 2038–2047
2046 Lv et al.presumably in their misfolded state. The use of long-lived
fluorophores (30,63) makes it possible to extend these
studies to the quantitative analysis of later self-assembly
stages such as trimer and tetramer, and work in this regard
is in progress. Note as well that the described tethered
approach is general and can be applied to any protein that
undergoes misfolding and self-assembly.SUPPORTING MATERIAL
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